factual
MDMA Phase 3 Removed PTSD Diagnosis in 70%
Across two Phase 3 studies of MDMA-assisted therapy for PTSD—the first with severe PTSD and the replication with moderate-to-severe PTSD—roughly 70% of participants lost their PTSD diagnosis, with remarkably similar outcomes across both studies despite the broadened population, a result far exceeding current gold-standard treatments.
factualpending
Speaker
Jennifer MitchellEvidence Quote
“approximately what 70 of the participants over the course of the two study lost their diagnosis of ptsd”
Created: 6/14/2026, 2:01:41 AM
Your notes
Loading notes...